News

Featured

Phasing out of extraordinary COVID-19 regulatory flexibilities

The European Medicines Agency (EMA) has officially declared the gradual discontinuation of exceptional regulatory flexibilities that were put in place during the COVID-19 pandemic. These flexibilities have been…

July 6, 2023

Featured

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

The European Medicines Agency (EMA) recently issued an essay outlining the main points of the Pharmacovigilance Risk Assessment Committee (PRAC) conference, which took place from July 3-6, 2023.…

July 7, 2023

Featured

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP)

The Committee for Veterinary Medicinal Products (CVMP) recently finished its conference, which focused on enhancing animal health and welfare from July 11 to 13, 2023. The approval of…

July 14, 2023